DarioHealth Corp. DRIO
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -7.29% | 6.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.29% | 6.75% | |||
| Cost of Revenue | -18.12% | -1.74% | |||
| Gross Profit | -0.21% | 13.13% | |||
| SG&A Expenses | -6.81% | -6.96% | |||
| Depreciation & Amortization | 0.56% | -2.21% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.59% | -6.53% | |||
| Operating Income | 11.36% | 14.63% | |||
| Income Before Tax | 7.28% | 8.45% | |||
| Income Tax Expenses | 475.44% | -31.33% | |||
| Earnings from Continuing Operations | 3.94% | 8.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.94% | 8.66% | |||
| EBIT | 11.36% | 14.63% | |||
| EBITDA | 12.10% | 15.48% | |||
| EPS Basic | 32.33% | 38.45% | |||
| Normalized Basic EPS | 34.67% | -10.01% | |||
| EPS Diluted | 32.33% | 38.45% | |||
| Normalized Diluted EPS | 34.67% | -10.01% | |||
| Average Basic Shares Outstanding | 41.95% | -16.79% | |||
| Average Diluted Shares Outstanding | 41.95% | -16.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||